World's Best Scientists 2026 revealed!
Award Badge
Medicine
Netherlands
2023

D-Index & Metrics

Medicine

D-Index
151
Citations
96630
World Ranking
1106
National Ranking
40

Jos H. Beijnen publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Jos H. Beijnen sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 1,719 publications — 99th percentile

99% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Jos H. Beijnen D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Jos H. Beijnen sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 151 D-Index — 95th percentile

95% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Research.com Recognitions

  • 2023 - Research.com Medicine in Netherlands Leader Award
  • 2010 - Royal Netherlands Academy of Arts and Sciences

Overview

Jos H. Beijnen is affiliated with Utrecht University in the Netherlands and has a significant body of research primarily in the field of Medicine, with a focus on Oncology, Molecular Biology, Pharmacology, Pulmonary and Respiratory Medicine, and Epidemiology.

Their work encompasses various topics, including:

  • Drug Transport and Resistance Mechanisms
  • Pharmacogenetics and Drug Metabolism
  • Colorectal Cancer Treatments and Studies
  • Cancer Treatment and Pharmacology
  • Lung Cancer Treatments and Mutations
  • Cancer therapeutics and mechanisms
  • Pharmacological Effects and Toxicity Studies

Frequent publication venues for Jos H. Beijnen include:

  • Journal of Chromatography B
  • Journal of Pharmaceutical and Biomedical Analysis
  • Clinical Pharmacokinetics
  • Cancer Chemotherapy and Pharmacology
  • Clinical Pharmacology & Therapeutics

Their recent published papers illustrate a strong focus on cancer-related pharmacology and immunotherapy:

  • "Tumor-Infiltrating Lymphocyte Therapy or Ipilimumab in Advanced Melanoma," 2022, New England Journal of Medicine
  • "Tumor infiltrating lymphocytes (TIL) therapy in metastatic melanoma: boosting of neoantigen-specific T cell reactivity and long-term follow-up," 2020, Journal for ImmunoTherapy of Cancer
  • "The Mechanism-Based Inactivation of CYP3A4 by Ritonavir: What Mechanism?", 2022, International Journal of Molecular Sciences
  • "Pharmacokinetics and Pharmacodynamics of PARP Inhibitors in Oncology," 2022, Clinical Pharmacokinetics
  • "Clinical Pharmacokinetics and Pharmacodynamics of the Cyclin-Dependent Kinase 4 and 6 Inhibitors Palbociclib, Ribociclib, and Abemaciclib," 2020, Clinical Pharmacokinetics

Jos H. Beijnen has worked alongside frequent co-authors such as:

  • Alwin D. R. Huitema
  • Hilde Rosing
  • Alfred H. Schinkel
  • Thomas P. C. Dorlo
  • Neeltje Steeghs

In recognition of scientific contributions, Jos H. Beijnen was awarded membership in the Royal Netherlands Academy of Arts and Sciences in 2010.

Best Publications

  • Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs

    A.H. Schinkel;J.J.M. Smit;O. van Tellingen;J.H. Beijnen

  • A Phase I and Pharmacological Study with Imidazolium-trans-DMSO-imidazole-tetrachlororuthenate, a Novel Ruthenium Anticancer Agent

    Jeany M. Rademaker-Lakhai;Desiree van den Bongard;Dick Pluim;Jos H. Beijnen

  • Limited oral bioavailability and active epithelial excretion of paclitaxel (Taxol) caused by P-glycoprotein in the intestine

    A. Sparreboom;J. van Asperen;U. Mayer;A.H. Schinkel

  • The breast cancer resistance protein protects against a major chlorophyll-derived dietary phototoxin and protoporphyria

    Johan W. Jonker;Marije Buitelaar;Els Wagenaar;Martin A. van der Valk

  • Role of Breast Cancer Resistance Protein in the Bioavailability and Fetal Penetration of Topotecan

    Johan W. Jonker;Johan W. Smit;Remco F. Brinkhuis;Marc Maliepaard

  • Miltefosine: a review of its pharmacology and therapeutic efficacy in the treatment of leishmaniasis

    Thomas P. C. Dorlo;Thomas P. C. Dorlo;Manica Balasegaram;Jos H. Beijnen;Peter J. de Vries

  • Stable isotopically labeled internal standards in quantitative bioanalysis using liquid chromatography/mass spectrometry: necessity or not?

    Ellen Stokvis;Hilde Rosing;Jos H. Beijnen;Jos H. Beijnen

  • A phase I study of the natural killer T-cell ligand alpha-galactosylceramide (KRN7000) in patients with solid tumors.

    Giuseppe Giaccone;Cornelis J. A. Punt;Yoshitaka Ando;Rita Ruijter

  • An update on in vitro test methods in human hepatic drug biotransformation research: pros and cons.

    Esther F.A Brandon;Christiaan D Raap;Irma Meijerman;Jos H Beijnen;Jos H Beijnen

  • Clinical pharmacokinetics of therapeutic monoclonal antibodies.

    Ron J. Keizer;Alwin D. R. Huitema;Jan H. M. Schellens;Jan H. M. Schellens;Jos H. Beijnen;Jos H. Beijnen

  • Approaching tumour therapy beyond platinum drugs : status of the art and perspectives of ruthenium drug candidates.

    A. Bergamo;C. Gaiddon;J.H.M. Schellens;J.H. Beijnen

  • Role of glutathione in the export of compounds from cells by the multidrug-resistance-associated protein

    G J Zaman;J Lankelma;O van Tellingen;J Beijnen

  • Multidrug-resistance protein 5 is a multispecific organic anion transporter able to transport nucleotide analogs

    J Wijnholds;C A Mol;L van Deemter;M de Haas

  • Clinical Pharmacokinetics of Cyclophosphamide

    Milly E de Jonge;Alwin D R Huitema;Sjoerd Rodenhuis;Jos H Beijnen

  • Increased sensitivity to anticancer drugs and decreased inflammatory response in mice lacking the multidrug resistance-associated protein.

    J. Wijnholds;R. Evers;M. R. Van Leusden;C. A. A. M. Mol

  • Phase I/II study with ruthenium compound NAMI-A and gemcitabine in patients with non-small cell lung cancer after first line therapy

    Suzanne Leijen;Sjaak A. Burgers;Paul Baas;Dick Pluim

  • Use of P-glycoprotein and BCRP inhibitors to improve oral bioavailability and CNS penetration of anticancer drugs.

    Pauline Breedveld;Jos H. Beijnen;Jos H. Beijnen;Jan H.M. Schellens;Jan H.M. Schellens

  • Pharmacokinetics of paclitaxel and metabolites in a randomized comparative study in platinum-pretreated ovarian cancer patients

    M.T. Huizing;A.C.F. Keung;H. Rosing;V. van der Kuij

  • Enhancing antitumor response by combining immune checkpoint inhibitors with chemotherapy in solid tumors

    K.M. Heinhuis;W. Ros;M. Kok;N. Steeghs

  • Full blockade of intestinal P-glycoprotein and extensive inhibition of blood-brain barrier P-glycoprotein by oral treatment of mice with PSC833.

    Ulrich Mayer;Els Wagenaar;Birgit Dorobek;Jos H. Beijnen

Frequent Co-Authors

Jan H.M. Schellens
Jan H.M. Schellens Utrecht University
Hilde Rosing
Hilde Rosing Antoni van Leeuwenhoek Hospital
Alfred H. Schinkel
Alfred H. Schinkel Antoni van Leeuwenhoek Hospital
Sjoerd Rodenhuis
Sjoerd Rodenhuis Antoni van Leeuwenhoek Hospital
David M. Burger
David M. Burger Radboud University
Emile E. Voest
Emile E. Voest Antoni van Leeuwenhoek Hospital
John B. A. G. Haanen
John B. A. G. Haanen Antoni van Leeuwenhoek Hospital
Joep M. A. Lange
Joep M. A. Lange University of Amsterdam
Piet Borst
Piet Borst Antoni van Leeuwenhoek Hospital

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you're considering a career in medicine, there are several alternative online degrees and pathways that can help you enter the healthcare field. Many students opt for nursing, especially with flexible absn programs that don't require teas, making it easier to start your nursing education without additional testing barriers.

For those interested in healthcare leadership roles, accelerated healthcare programs offer a fast track to earning a degree in healthcare administration online. These programs are ideal for students wanting to move quickly into management positions within the healthcare sector.

Registered nurses seeking career advancement may consider rn to np bridge programs. These bridge programs provide a smooth transition from an associate degree in nursing to a nurse practitioner role, opening doors to greater responsibility and higher pay.

If you’re passionate about wellness and nutrition, a best online nutrition degree can help you prepare for careers in dietary planning, public health, and nutritional counseling. Online learning has made it easier than ever to pursue these rewarding pathways alongside your existing commitments.

Best Scientists Citing Jos H. Beijnen

Trending Scientists